Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Infographic – America’s Immigration Advantages

Trade Vistas, a project of the Center for Strategic and International Studies in Washington, D.C., compiled a chart outlining the benefits to the U.S. from immigration. . . . → Read More: Infographic – America’s Immigration Advantages

Report: Health System Not Ready for Alzheimer’s Therapies

A new study finds the U.S. health care system does not have the capacity for large-scale screening and treatment of people with early indicators of Alzheimer’s disease. . . . → Read More: Report: Health System Not Ready for Alzheimer’s Therapies

Infographic: Largest Hacker Breaches and Regulation Tech

Among the most visible and challenging regulatory issues for companies is security breaches, where companies’ systems are attacked with valuable data stolen. . . . → Read More: Infographic: Largest Hacker Breaches and Regulation Tech

Open-Source Model Devised to Value Medical Technologies

An initiative joining most major health care stakeholders is developing models to calculate the value of medical treatments, with a process described as open and transparent. . . . → Read More: Open-Source Model Devised to Value Medical Technologies

Ways to Invest Without Playing the Stock Market

Taking your chances on the stock market right now is not only a scary prospect but may not be the best idea right now. . . . → Read More: Ways to Invest Without Playing the Stock Market

Cancer Drug Price Rises Shown Unrelated to Competition

An analysis of cancer drugs shows their prices steadily increased over 16 years despite competition from newer drugs on the market. . . . → Read More: Cancer Drug Price Rises Shown Unrelated to Competition

Here’s What a Real Opioid Emergency Looks Like

Let’s be clear — the limited steps ordered by the president to reduce the numbers of people addicted to opioids don’t look anything like a response to an emergency. . . . → Read More: Here’s What a Real Opioid Emergency Looks Like

Biosimilars Seen Saving U.S. $54 Billion

An analysis of health care costs shows increasing the use of substitute biologic treatments known as biosimilars could save the United States some $54 billion over 10 years. . . . → Read More: Biosimilars Seen Saving U.S. $54 Billion

Flashback: Drug Pricing Reform Even Big Pharma Might Like

Science & Enterprise is taking a break From 2 to 13 October. Until then, we will re-run some of our recent special reports. Our regular posts will return on 16 October.

(TBIT/Pixabay)

2 May 2016. At a press event in Washington, D.C. last week, Representative Lloyd Doggett of Texas, a champion of lower prescription . . . → Read More: Flashback: Drug Pricing Reform Even Big Pharma Might Like

Infographic – Numbers of Atlantic Hurricanes

Our friends at Statista prepared a chart yesterday that gives the number of hurricanes in the Atlantic from 1967 through 2015. . . . → Read More: Infographic – Numbers of Atlantic Hurricanes